Systemic and intratumoral 9-valent human papillomavirus vaccine treatment for squamous cell carcinoma in situ in a renal transplant recipient

Anna J Nichols; Valeria De Bedout; Rachel A Fayne; George W Burke; Robert S Kirsner; Tim Ioannides

doi:10.1016/j.jdcr.2020.02.002

Systemic and intratumoral 9-valent human papillomavirus vaccine treatment for squamous cell carcinoma in situ in a renal transplant recipient

JAAD Case Rep. 2020 Mar 25;6(4):289-291. doi: 10.1016/j.jdcr.2020.02.002. eCollection 2020 Apr.

Authors

Anna J Nichols^{1

2}, Valeria De Bedout¹, Rachel A Fayne¹, George W Burke³, Robert S Kirsner^{1

2}, Tim Ioannides⁴

Affiliations

¹ University of Miami Miller School of Medicine, Dr Philip Frost Department of Dermatology and Cutaneous Surgery, Miami, Florida.
² Sylvester Comprehensive Cancer Center, Miami, Florida.
³ University of Miami Miller School of Medicine, Miami Transplant Institute Jackson Health System, Miami, Florida.
⁴ Treasure Coast Dermatology, Port St. Lucie, Florida.

No abstract available

Keywords: HPV, human papillomavirus; IM, intramuscular; SCCIS, squamous cell carcinoma in situ; SOTR, solid organ transplant recipient; human papillomavirus vaccine; solid organ transplant recipient; squamous cell carcinoma in situ.

Publication types

Case Reports